Rosa rugosa flavonoids exhibited PPAR-alpha agonist-like effects on genetic severe hypertriglyceridemia of mice
Preclinical
Abstract
Rosa rugosa, traditionally used to treat cardiovascular diseases and risk factors such as hyperlipidemia and hypertension, was tested in genetically severe hypertriglyceridemic mice. Its flavonoids exhibited PPAR-alpha agonist-like effects, lowering triglycerides, supporting the cardiovascular use of rugosa rose.
Referenced for these plants
How to cite
Baiyisaiti, A., Liu, Y., Zhang, J. and Yang, R (2019) 'Rosa rugosa flavonoids exhibited PPAR-alpha agonist-like effects on genetic severe hypertriglyceridemia of mice', Journal of Ethnopharmacology, 240, pp. 111952. doi:10.1016/j.jep.2019.111952
This reference is part of the evidence base for the Omnia Sana plant database. Source links open the original publication; Omnia Sana does not host third-party content.